Pfizer Inc (PFE.N) plans to cut about 20 percent of its sales force for primary-care drugs, Bloomberg News reported, as the pharmaceutical company copes with the loss of a patent for top-selling cholesterol drug Lipitor.
The staff cuts will amount to about 600 sales people out of 3,000, and will begin this month, Bloomberg said, citing a person familiar with the matter.
Choosen excerpts by Job Market Monitor from
via Pfizer to cut 600 jobs as Lipitor sales decline: report | Reuters.
Job Market Monitor 
Discussion
Trackbacks/Pingbacks
Pingback: Merck / To cut 8,500 jobs | Job Market Monitor - October 1, 2013
Pingback: Teva / The drug company to cut 5,000 jobs | Job Market Monitor - October 10, 2013
Pingback: Layoffs in Pharmaceutical Industry / Due to Productivity Crisis in R&D ? | Job Market Monitor - October 11, 2013
Pingback: Pharmaceutical / The Skills Gap | Job Market Monitor - November 20, 2013
Pingback: Forest Labs / To cut jobs to save $110 million | Job Market Monitor - December 2, 2013